Call for Papers for a Special Issue on “Role of G-proteins and GPCR-Mediated Signaling in The Pathophysiology and Treatment of Psychiatric Disorders” – Deadline for manuscript submission extended to January 31, 2021
Guest Editors: Yuji Odagaki and Javier J. Meana
Pharmacological Reports plans to launch a special issue devoted to outline advances on involvement of GPCR pathways in the nature, causes, mechanisms and treatments of mental disorders. Contributions may include a broad range of topics related to experimental and clinical pharmacology addressing molecular, cellular, neurochemical, circuitries, neuroimaging, behavioral and drug discovery areas. Translational investigations whose primary focus deals with involvement of GPCR signaling in mental disorder mechanisms and treatments are encouraged. Candidate papers will be submitted to a peer-review process to guarantee excellence of scientific results for research and educational purposes.
Manuscripts describing original results on any aspect related to the topic will be considered for publication provided that they report significant new findings with full experimental details. Narrative and systematic reviews will be also considered if they represent synthesized new insight into the neurobiology and neuropsychopharmacology of GPCR signaling.
Our deadline for submission will be January 31, 2021, with an anticipated publication date of summer 2021.
Pharmacological Reports Editor:
- Katarzyna Fijał (firstname.lastname@example.org)